FDA panel votes against approving Intellipharma's opioid painkiller – Reuters
WSBT-TV |
FDA panel votes against approving Intellipharma’s opioid painkiller
Reuters (Reuters) – A panel of independent advisers to the U.S. Food and Drug Administration overwhelmingly concluded on Wednesday that there is not enough evidence to support approval of Intellipharmaceutics International Inc’s long-acting opioid painkiller. FDA panel votes against ‘abuse-deterrent’ opioid with blue dye FDA Committee Votes Down Approval Of Abuse-Deterrent Opioid |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.